Abstract
Mutations in human Cu,Zn-superoxide dismutase (SOD1) cause approximately 20% of familial amyotrophic lateral sclerosis (FALS) cases. The mechanism of late-onset disease manifestation despite the innate mutation has no clear explanation. The relationship between homocysteine (HC) and amyotrophic lateral sclerosis (ALS) has not been investigated, in spite of the similarity in their pathogenesis. We investigated the effect of HC on the motor neuronal cell-line transfected with SOD1 of either wild-type or one of two mutant forms (G93A and A4V). In the MTT assay, HC induced significant cytotoxicity in A4V, but not in G93A, as compared with wild-type, even at the physiological concentration of 10 microM. This HC-induced cytotoxicity was inhibited by the antioxidant trolox and the Cu (I) chelator bathocuproinedisulfonate. Here we show that the vulnerability of the A4 V mutant involves the cytotoxic copper-mediated pathway, and that HC may be a lifelong precipitating factor in some forms of FALS, suggesting the possible treatment modality with vitamin supplements.
References
Nov 25, 1995·Lancet·I J PerryA G Shaper
Jun 1, 1994·Human Molecular Genetics·D R RosenR J Ferrante
Jan 26, 1996·Science·M Wiedau-PazosD E Bredesen
Apr 19, 1996·Science·M A De GrooteF C Fang
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·M B YimE R Stadtman
Oct 1, 1996·Neurology·D E BredesenJ S Valentine
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·J Ross
Feb 1, 1997·Annals of Neurology·M E CudkowiczR H Brown
Apr 4, 1997·The Journal of Biological Chemistry·H S YimM B Yim
May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·S A LiptonJ S Stamler
Jul 25, 1997·Atherosclerosis·G R UpchurchJ Loscalzo
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·L B CorsonD W Cleveland
Jun 18, 1998·Annals of Neurology·M E CudkowiczR H Brown
Jan 8, 2000·The Journal of Biological Chemistry·J J GotoD E Cabelli
Feb 19, 2000·The American Journal of Clinical Nutrition·J SelhubI H Rosenberg
Sep 2, 2000·Current Opinion in Neurology·A Al-Chalabi, P N Leigh
Oct 13, 2000·Archives of Neurology·R Diaz-Arrastia
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·P PasinelliD W Cleveland
Mar 10, 2001·Journal of Neurochemistry·A R WhiteR Cappai
Jul 14, 2001·Biochimica Et Biophysica Acta·F YamakuraK Uchida
Aug 24, 2001·The Journal of Biological Chemistry·M A JohnsonB Gaston
Citations
Mar 26, 2003·Brain Research·Yoon Hee ChungChoong Ik Cha
Aug 8, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F ValentinoV La Bella
Nov 24, 2011·Toxicology and Applied Pharmacology·Richelle A HemendingerBenjamin Rix Brooks
Jan 18, 2011·Toxicology and Applied Pharmacology·Richelle A HemendingerBenjamin Rix Brooks
Dec 23, 2015·Journal of Cell Communication and Signaling·Ahmet MenteseSelim Demir
Apr 26, 2008·Neuropharmacology·Xiaojie ZhangWeidong Le
Jul 28, 2005·The European Journal of Neuroscience·Seong-Ho KohSeung Hyun Kim
Mar 25, 2004·Aging Cell·Lindsay TjiattasThomas B Shea
Jul 6, 2005·Toxicology·Seong-Ho KohSeung Hyun Kim
Apr 13, 2005·Brain Research·Fernanda BonattoJosé Cláudio Fonseca Moreira
Feb 21, 2008·Nutritional Neuroscience·Maya Dubey, Thomas B Shea
Feb 7, 2015·BMC Neuroscience·Jin-Young ChungManho Kim
Mar 6, 2012·Genetic Testing and Molecular Biomarkers·Ali SazciHalil Atilla Idrisoglu
Jun 25, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Stefano ZoccolellaGiancarlo Logroscino
Feb 12, 2017·Neurologia i neurochirurgia polska·Kamila Żur-WyrozumskaTomasz Dziedzic
Oct 24, 2002·Current Opinion in Clinical Nutrition and Metabolic Care·Amy Cameron, Jeffrey Rosenfeld